UnitedHealth Group (NYSE:UNH) updated its FY19 earnings guidance on Monday. The company provided earnings per share guidance of approach $15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.83. The company issued revenue guidance of ~$242 billion, compared to the consensus revenue estimate of $242.73 billion.UnitedHealth Group also updated its FY20 guidance to $16.25-16.55 EPS.
Several brokerages have recently commented on UNH. UBS Group decreased their price target on UnitedHealth Group from $281.00 to $257.00 and set a neutral rating on the stock in a research note on Thursday, October 17th. Mizuho reaffirmed a buy rating and issued a $300.00 price target (up previously from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Credit Suisse Group set a $293.00 price objective on UnitedHealth Group and gave the company a buy rating in a report on Thursday, August 29th. Jefferies Financial Group downgraded UnitedHealth Group from a buy rating to a hold rating and cut their price objective for the company from $300.00 to $235.00 in a report on Thursday, October 10th. Finally, Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a buy rating in a report on Tuesday, October 15th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus target price of $289.39.
Shares of UNH stock traded down $0.21 on Monday, hitting $279.66. The stock had a trading volume of 2,517,060 shares, compared to its average volume of 4,483,900. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.70 and a quick ratio of 0.70. The firm has a market capitalization of $265.15 billion, a P/E ratio of 21.71, a P/E/G ratio of 1.48 and a beta of 0.64. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $287.94. The company’s 50 day moving average price is $258.05 and its 200-day moving average price is $245.34.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The firm had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. During the same quarter in the previous year, the business earned $3.41 EPS. The company’s quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group will post 14.96 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. The ex-dividend date is Friday, December 6th. This represents a $4.32 annualized dividend and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.54%.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the company’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the sale, the chief accounting officer now owns 21,687 shares in the company, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 38,577 shares of company stock worth $9,398,080. 0.82% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is the operating income formula?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.